Rephonic
Artwork for The Emerging Biotech Leader

The Emerging Biotech Leader

SSI Strategy
Clinical Trials
Biotechnology
Rare Diseases
Drug Development
Clinical Operations
Biotech
Risk Management
Patient-Centered Drug Development
Biotech Industry
SSI Strategy
Medical Devices
Cardiovascular Disease
Real World Evidence
Board Governance
Regulatory Framework
Biotech Leadership
Patient-Focused Drug Development
Drug Safety
Strategic Planning
Clinical Development

Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from c... more

PublishesMonthlyEpisodes66Founded4 years ago
Number of ListenersCategories
BusinessLife SciencesScience

Listen to this Podcast

Artwork for The Emerging Biotech Leader

Latest Episodes

Moving from academia to biotech requires scientists to apply their expertise in a different environment. In this episode of The Emerging Biotech Leader podcast, Kim Kushner and Mattia Calissano, VP Medical at SSI Strategy, discuss moving from academi... more

For scientific founders, moving from academia into a biotech startup means turning personal expertise into organizational capability. 

In this episode of The Emerging Biotech Leader, Kim Kushner is joined by Samir Ounzain, co-founder and CEO of HAYA... more

YouTube

In this episode of The Emerging Biotech Leader, Kim Kushner sits down with Chris Kennedy, CEO of Pacific Genetech, to examine a different approach to building leadership teams in early-stage biotech: building organizations around program needs rather... more

YouTube

Rare disease programs force teams to confront operational realities much earlier in development, particularly when advanced modalities, limited patient populations, and complex site requirements intersect. 

In this episode of The Emerging Biotech Le... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
The Daily
The DailyThe New York Times
Radiolab
RadiolabWNYC Studios

Recent Guests

Samir Ounzain
Scientific founder and CEO of HAYA Therapeutics
HAYA Therapeutics
Episode: When the Science Becomes a Company
Chris Kennedy
CEO of Pacific Genetech; biotech executive with fractional leadership focus
Pacific Genetech
Episode: Flexible Leadership in Biotech: Building Teams Around Program Needs
Brendan Slagle
Lead, Clinical Operations at SSI Strategy
SSI Strategy
Episode: Designing Studies that Work in Complex Settings
Marshall Summar
CEO and founder of Uncommon Cures
Uncommon Cures
Episode: Rethinking Trial Design for Rare Diseases
Nicky Wisner
Leader of the Managed Access Practice at the Clinigen Group
Clinigen Group
Episode: Driving Global Patient Access: Managed Access as a Strategic Lever
Matt Trudeau
President of ITF Therapeutics
ITF Therapeutics
Episode: Rare Disease Commercialization: Beyond Approval
Meaghan Powers
Senior Director of Clinical Operations at SSI Strategy
SSI Strategy
Episode: Clinical Operations as a Strategic Function
Sharon Arnold
Clinical operations leader with 20+ years in biopharma and biotech
Anthos (Novartis company)
Episode: How Clinical Operations Shapes Biotech Strategy
Adriana Valenciano
Head of client delivery team
SSI Strategy (client delivery)
Episode: Biotech Leadership: The CEO–CMO Dynamic

Hosts

Kim Kushner
Host of The Emerging Biotech Leader; SSI Strategy
Ramin Farhood
Co-host of The Emerging Biotech Leader

Reviews

5.0 out of 5 stars from 18 ratings
  • Great series of guests!

    SSI brings in such an interesting array of guests to their show- I am always to see who will be next!

    Apple Podcasts
    5
    Livvvggg
    United States3 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Guests bring deep, actionable biotech ops insights across topics.
Great series of guests!
The host and guest dynamics feel authentic and practical.

Talking Points

Recent interactions between the hosts and their guests.

Rethinking Trial Design for Rare Diseases
Q: How should trial design address access and reimbursement?
Design trials with broad, real-world applicability in mind, using outcomes that align with payer and regulatory expectations, and consider including populations that reflect the disease's real-world impact, such as pediatric patients when appropriate.
Rethinking Trial Design for Rare Diseases
Q: What differentiates Uncommon Cures from a typical CRO?
Uncommon Cures operates end-to-end with in-house sites, nursing staff, design teams, and practical capabilities to run rare-disease trials from early development to post-marketing, enabling more efficient and patient-centered studies.
Adapting Biotech Leadership Across Development and Therapies
Q: What role does time play in the process and how can companies slow down to speed up effectively?
Time is precious; the speakers recommend upfront planning, scenario planning, and deliberate pacing to prevent later setbacks, with a focus on shared understanding and transparent communication to keep the organization moving together.
Adapting Biotech Leadership Across Development and Therapies
Q: How should leaders think about building a cohesive team across modalities like devices, cell and gene, and biologics?
The guest emphasizes aligning around a North Star, establishing a strong cross-functional team early, and integrating the narrative for regulators, physicians, patients, and payers to avoid silos and delays; bringing in external experts when needed is encouraged.
Adapting Biotech Leadership Across Development and Therapies
Q: What are the key differences between leading in early development versus late development?
Benit explains that early leadership must balance regulatory expectations with the potential for broader patient access and reimbursement, while late development requires deeper focus on medical affairs, evidence generation, and market access strategies; the thread is to align the narrative across stakeholders from the start.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Emerging Biotech Leader

What is The Emerging Biotech Leader about and what kind of topics does it cover?

A biotech-focused show that brings together senior operators, founders, and CMOs to unpack the realities of building and launching therapies. Episodes cover scientific translation to patient medicines, modular leadership and fractional roles, designing rare-disease trials, global access strategies, and the evolving role of clinical operations as a strategic function. Guests span scientific founders, biotech executives, and operations leaders, with practical guidance on team design, governance, patient-centric development, and market access. Notably, the mix of fractional leadership, patient-centered trial design, and end-to-end commercialization discussions helps listeners understand how to align science, operations, and business strategy u... more

Where can I find podcast stats for The Emerging Biotech Leader?

Rephonic provides a wide range of podcast stats for The Emerging Biotech Leader. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Emerging Biotech Leader and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Emerging Biotech Leader get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for The Emerging Biotech Leader, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Emerging Biotech Leader?

Rephonic provides comprehensive predictive audience data for The Emerging Biotech Leader, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Emerging Biotech Leader have?

To see how many followers or subscribers The Emerging Biotech Leader has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Emerging Biotech Leader?

These podcasts share a similar audience with The Emerging Biotech Leader:

1. Business Of Biotech
2. BioCentury This Week
3. Biotech Hangout
4. The Daily
5. Radiolab

How many episodes of The Emerging Biotech Leader are there?

The Emerging Biotech Leader launched 4 years ago and published 66 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Emerging Biotech Leader?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Emerging Biotech Leader?

Rephonic pulls ratings and reviews for The Emerging Biotech Leader from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Emerging Biotech Leader?

Rephonic provides full transcripts for episodes of The Emerging Biotech Leader. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Emerging Biotech Leader?

Recent guests on The Emerging Biotech Leader include:

1. Samir Ounzain
2. Chris Kennedy
3. Brendan Slagle
4. Marshall Summar
5. Nicky Wisner
6. Matt Trudeau
7. Meaghan Powers
8. Sharon Arnold

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days